Your daily review of the biggest winners & losers from the trading day, plus notable market-moving news.
Solar headlines explode, meme revenue surges, and dilution fears crush two micro-caps.
Buybacks lit the fuse, cancer data impressed, and the FDA crushed a biotech approval dream.
Activists spark a surge, diagnostics beats guidance, and FDA setbacks crush biotech optimism.
Governance flexibility sparks a surge, cancer data moves up fast, and dilution slams sellers.